Patents by Inventor Jill R. Schoenfeld

Jill R. Schoenfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for the Treatment of Systemic Lupus Erythematosis
    Publication number: 20090054300
    Abstract: The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases
    Type: Application
    Filed: March 2, 2004
    Publication date: February 26, 2009
    Inventors: Alexander Abbas, Sarah C. Bodary, Hilary Clark, Jill R. Schoenfeld, P. Mickey Williams, William I. Wood, Thomas D. Wu
  • Compositions and methods for the treatment of immune related diseases
    Publication number: 20040258678
    Abstract: The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: February 21, 2003
    Publication date: December 23, 2004
    Applicant: Genentech, Inc.
    Inventors: Sarah C. Bodary, Hilary Clark, Brisdell Hunte, Janet K. Jackman, Jill R. Schoenfeld, P. Mickey Williams, William I. Wood, Thomas D. Wu
  • Compositions and methods for the treatment of immune related diseases
    Publication number: 20040138114
    Abstract: The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: July 8, 2003
    Publication date: July 15, 2004
    Applicant: Genentech, Inc.
    Inventors: Henry Chiu, Hilary Clark, Kathryn Dennis, Sherman Fong, Jill R. Schoenfeld, William I. Wood, Thomas Wu
  • Receptor selective BNP
    Patent number: 6028055
    Abstract: Compounds related to BNP have reduced binding affinity for the natriuretic peptide receptor-C but possess improved or equivalent affinity to the wild type BNP for natriuretic peptide receptor-A. The BNP related compounds are suitable for use in the treatment or prophylaxis of various pathological conditions associated with water or electrolyte imbalance.
    Type: Grant
    Filed: October 21, 1997
    Date of Patent: February 22, 2000
    Assignee: Genetech, Inc.
    Inventors: David G. Lowe, Jill R. Schoenfeld